3 ms·
in my experience, it is still pretty common, depending on the development stage and drug indication. It is not done without good reason. As mentioned elsewhere,
by s1artibartfast 5y ago
in my experience, it is still pretty common, depending on the development stage and drug indication. It is not done without good reason. As mentioned elsewhere, there are pleanty of practical reason. The challenge with single sex studies isn't about Journals or IRBs, neither of which care, it is about FDA approval for marketing